Recently Searched
OCTOTIDE 0.05mg Injection 1's
Choose Generic substitutes to Save up to 50% off 
₹0
INTRODUCTION
OCTOTIDE 0.05MG INJECTION contains Octreotide which belongs to the group of medicines called Octapeptides. It is used to treat acromegaly (a condition in which the body produces too much growth hormone), neuroendocrine tumors in the gut (Ex. appendix, small intestine or colon) and pituitary tumors that make too much thyroid-stimulating hormone (TSH).
OCTOTIDE 0.05MG INJECTION is also used to prevent complications after surgery of the pancreas, to stop bleeding and protect from re-bleeding from ruptured gastro-esophageal varices (abnormal veins) in patients suffering from cirrhosis (chronic liver disease) and to relieve symptoms associated with excess production of certain hormones and other related substances by the stomach, bowels or pancreas.
Before receiving OCTOTIDE 0.05MG INJECTION, inform your doctor if you have gallstones, diabetes or a history of vitamin B12 deprivation. OCTOTIDE 0.05MG INJECTION should be used in pregnant women only if considered clearly necessary. Women of child-bearing capability should use an effective contraceptive method during treatment.
OCTOTIDE 0.05MG INJECTION is not recommended for use among breastfeeding women. There is little experience with the use of OCTOTIDE 0.05MG INJECTION in children so, consult your child’s doctor for advice. During treatment, your doctor may wish to check your thyroid, liver and pancreatic enzyme function periodically.
The most common side effects of receiving OCTOTIDE 0.05MG INJECTION are sudden back pain, changes in heart rate, appetite or weight, yellow skin and eyes, slow heartbeat, etc. Contact your doctor for advice if any of the symptoms worsen.
USES OF OCTOTIDE 0.05MG INJECTION
OCTOTIDE 0.05MG INJECTION is used to:
- treat acromegaly
- treat neuroendocrine tumors in the gut (Ex. appendix, small intestine or colon)
- treat pituitary tumors that make too much thyroid-stimulating hormone (TSH)
- prevent complications after surgery of the pancreas
- to relieve symptoms associated with excess production of certain hormones and other related substances by the stomach, bowels or pancreas
- stop bleeding and protect from re-bleeding from ruptured gastro-esophageal veins in patients suffering from cirrhosis
HOW OCTOTIDE 0.05MG INJECTION WORKS
OCTOTIDE 0.05MG INJECTION relieves the symptoms of acromegaly and overproduction of other hormones by inhibiting the release of certain hormones such as growth hormone and also by reducing the size of pituitary gland (which is enlarged in acromegaly). OCTOTIDE 0.05MG INJECTION also helps to control bleeding and reduce transfusion requirements in patients with ruptured gastro-oesophageal varices.
DIRECTIONS FOR USE
OCTOTIDE 0.05MG INJECTION will be given to you only by a doctor or a nurse into upper arms, thighs or abdomen as a subcutaneous injection. The correct dose and duration of OCTOTIDE 0.05MG INJECTION treatment will be decided by your doctor for you depending on your age, body weight and disease condition.
SIDE EFFECTS OF OCTOTIDE 0.05MG INJECTION
COMMON
- gallstones (causing sudden back pain)
- excess or low blood sugar
- hypothyroidism (underactive thyroid gland which causes changes in heart rate, appetite or weight, tiredness, feeling cold or swelling at the front of the neck)
- changes in thyroid function tests
- cholecystitis (inflammation of the gallbladder causing pain in the upper right abdomen, fever, nausea, yellowing of the skin and eyes)
- impaired glucose tolerance
- slow heartbeat
- diarrhoea, stomach pain, nausea, constipation, wind, loss of appetite
- headache, dizziness
- local pain at the injection site
- stomach discomfort after meal, vomiting, feeling full
- fatty or loose stools, discolored faeces
- change in liver function tests
- hair loss
- shortness of breath
- weakness
UNCOMMON
- feeling thirsty, dark urine, low urine output, dry flushed skin
- fast heartbeat
RARE
- acute bowel obstruction, with progressive abdominal swelling, severe upper stomach pain, tender stomach and stomach contractions
Stop receiving OCTOTIDE 0.05MG INJECTION and contact your doctor immediately if you experience any of the following side effects:
- hypersensitivity (allergic) reactions including skin rash
- anaphylaxis (a type of allergic reaction which can cause difficulty in swallowing or breathing, swelling and tingling, possibly with a drop in blood pressure with dizziness)
- pancreatitis (inflammation of the pancreas causing sudden pain in the upper abdomen, nausea, vomiting, diarrhea)
- hepatitis (liver inflammation causing yellowing of the skin and eyes, nausea, vomiting, loss of appetite, generally feeling unwell, itching, light-colored urine)
- irregular heart heartbeat
- low level of blood platelet (increased bleeding or bruising)
HOW TO MANAGE SIDE EFFECTS
Nausea or Vomiting:
Stick to simple meals and avoid oily or spicy foods, sugary snacks and aerated drinks. Avoid drinking too much liquid or water together with your meals and slowly drink in between meals. If symptoms persist, contact your doctor.
Diarrhea:
Keep yourself hydrated by drinking lots of fluids, such as water or fruit juice. Do not consume any medicine on your own without consulting your doctor. If symptom persists, contact your doctor.
Stomach pain:
Try to rest and relax. Eat and drink slowly or try to have lesser and very frequent meals. Keep a heating pad on your stomach. If symptom persists, contact your doctor.
WARNING & PRECAUTIONS
PREGNANCY
OCTOTIDE 0.05MG INJECTION should be used in pregnant women only if considered clearly necessary. Women of child-bearing capability should use an effective contraceptive method during treatment. Consult your doctor before receiving it.
BREASTFEEDING
OCTOTIDE 0.05MG INJECTION is not recommended for use in breastfeeding women as it may pass through breast milk. Consult your doctor before receiving it.
DRIVING AND USING MACHINES
Do not drive or operate any machines if you experience headache or tiredness after receiving OCTOTIDE 0.05MG INJECTION.
KIDNEY
Dose adjustment of OCTOTIDE 0.05MG INJECTION is required in patients with kidney impairment or those with kidney failure requiring dialysis. Consult your doctor before receiving it.
LIVER
OCTOTIDE 0.05MG INJECTION should be used with caution in patients having liver cirrhosis. Consult your doctor before receiving it.
ALLERGY
Do not receive OCTOTIDE 0.05MG INJECTION if you are allergic to octreotide or any of the other ingredients of this medicine.
OTHERS
Before receiving OCTOTIDE 0.05MG INJECTION, inform your physician if you have:
- or had gallstones at present or have had them in the past
- diabetes
- a history of vitamin B12 deficiency
Use in pediatrics:
There is little experience with the use of OCTOTIDE 0.05MG INJECTION in children so, consult your child’s doctor for advice.
Use in geriatrics:
OCTOTIDE 0.05MG INJECTION should be used with caution in elderly patients. Consult your doctor before receiving it.
INTERACTIONS
A. Drug-Drug interactions:
Before receiving OCTOTIDE 0.05MG INJECTION, inform your doctor if you are taking any of the following medicines:
- medicines used as immunosuppressants (Ex. ciclosporin)
- bromocriptine (used to treat Parkinson’s disease)
- medicines used to treat heart rhythm problems (Ex. quinidine)
- medicines used to relieve allergies (Ex. terfenadine)
- medicines used to control blood pressure (Ex. amlodipine, atenolol)
- medicines used to control body fluid and electrolyte balance (Ex. furosemide, spironolactone)
- insulin (used to treat diabetes)
- cimetidine (used to reduce acidity)
- lutetium (177Lu) oxodotreotide (radiotherapy used for treatment of certain tumors)
Overdosage:
OCTOTIDE 0.05MG INJECTION will be administered to you only by a doctor or a nurse in a hospital and so it is unlikely to receive an overdose. However, call your physician or nurse if you experience any unusual symptoms.
SYNOPSIS
| Drug | : | Octreotide |
| Pharmacological Category | : | Octapeptides |
| Therapeutic Indication | : | Acromegaly, Gut and pituitary tumors, to prevent complications after pancreatic surgery of the pancreas, to control bleeding from ruptured gastro-esophageal varices |
| Dosage Forms | : | Injection |
MORE INFORMATION
- Keep OCTOTIDE 0.05MG INJECTION out of reach of children
- Store OCTOTIDE 0.05MG INJECTION in a refrigerator at 2-8°C
FAQs ABOUT OCTOTIDE 0.05MG INJECTION
What if I miss to receive a dose of OCTOTIDE 0.05MG INJECTION?
Please stick to the prescribed schedule as agreed with your doctor for optimal efficacy of OCTOTIDE 0.05MG INJECTION treatment. Notify your doctor if you miss to receive any dose.
Can I stop receiving OCTOTIDE 0.05MG INJECTION if I feel better?
If you interrupt your treatment, your symptoms may come back. Therefore, do not stop using OCTOTIDE 0.05MG INJECTION unless your doctor tells you to. Consult your doctor for further queries.
Does it hurt at the injection site after receiving OCTOTIDE 0.05MG INJECTION?
A few people experience pain at the site of the subcutaneous injection after receiving OCTOTIDE 0.05MG INJECTION. This pain usually only lasts a short time and you can relieve this by gently rubbing the site of injection for a few seconds afterwards. Consult your doctor it worries you.
Is it safe to use OCTOTIDE 0.05MG INJECTION in pregnancy?
OCTOTIDE 0.05MG INJECTION should be used in pregnant women only if considered clearly necessary. Women of child-bearing capability should use an effective contraceptive method during treatment. Consult your doctor before receiving it.
Can OCTOTIDE 0.05MG INJECTION be used in children?
There is little experience with the use of OCTOTIDE 0.05MG INJECTION in children so, consult your child’s doctor for advice. The physician will determine a proper dose or select a suitable alternative treatment for your child.
REFERENCES
1. KD. Tripathi. Anterior Pituitary Hormones. Essentials of Medical Pharmacology. Eighth edition. 2019. Page – 260.
2. R Chaudhary, Balwinder Singh and P Subhas. Octreotide in Gastroenterology. NIH National Library of Medicine, National center for biotechnology information. Pubmed Central. June 2017. [Accessed on 7th June 2022]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531086/
3. Novartis Pharmaceuticals. Efficay/Safety of Octreotide Acetate in Patients with Uncontrolled Acromegaly. NIH U.S. National Library of Medicine. ClinicalTrials.gov. [Revised in May 2011] [Accessed on 7th June 2022]. https://clinicaltrials.gov/ct2/show/NCT00372697
4. Novartis Pharmaceuticals UK Limited. Electronic Medicines Compendium (EMC). [Revised in May 2022] [Accessed on 7th June 2022]. https://www.medicines.org.uk/emc/files/pil.7828.pdf
5. Sun Pharmaceutical Industries Europe B.V. Electronic Medicines Compendium (EMC). [Revised in June 2022] [Accessed on 7th June 2022]. https://www.medicines.org.uk/emc/files/pil.6404.pdf
6. Novartis Pharmaceuticals Corporation. SANDOSTATIN LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use. [Revised in March 2021] [Accessed on 7th June 2022]. https://www.novartis.com/us-en/sites/novartis_us/files/sandostatin_lar.pdf
USEFUL DIAGNOSTIC TESTS
- Growth hormone suppression test
AUTHOR DETAILS
Written By Dr. Jeenal Rajani, Pharm.D.
Last updated on 30 Nov 2022 | 10:15 PM(IST)
PRODUCT DETAILS
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.